A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
NCT ID: NCT03617939
Last Updated: 2025-11-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
20000 participants
OBSERVATIONAL
2015-09-16
2037-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Biospeciman and Data Collection
Patients with cancer or who are at risk of having cancer who have given consent to have blood, tissue, other biological samples and their associated data (survey data, medical records data, cancer registry data, and other related data) collected and stored for the advancement of medicine.
Biospeciman Collection
Collection of blood, tissue, and other biological samples.
Survey Assessments
Data taken from patient surveys and assessments, including quality of life.
Medical Chart Reviews
Data taken directly from the patients' medical charts.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Biospeciman Collection
Collection of blood, tissue, and other biological samples.
Survey Assessments
Data taken from patient surveys and assessments, including quality of life.
Medical Chart Reviews
Data taken directly from the patients' medical charts.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Diagnosed with cancer, or may be at risk for cancer.
3. Able to understand and sign the TCCP Informed Consent and Research Authorization form directly or through a legally authorized representative (LAR).
Non-English speaking subjects will also be invited to participate in the TCCP study, in accordance with COMIRB's short-form consent use.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Colorado, Denver
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Virginia Borges, MD
Role: PRINCIPAL_INVESTIGATOR
University of Colorado, Denver
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Colorado Hospital
Aurora, Colorado, United States
UCHealth Memorial Hospital Central
Colorado Springs, Colorado, United States
UCHealth Memorial Hospital North
Colorado Springs, Colorado, United States
Cherry Creek Medical Center
Denver, Colorado, United States
UCHealth Poudre Valley Health System
Fort Collins, Colorado, United States
Highlands Ranch Medical Center
Highlands Ranch, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Virgina Borges, MD
Role: primary
Sara Twombly
Role: primary
Alicia Deschaine
Role: primary
Nathan Ketelhut
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15-1110.cc
Identifier Type: -
Identifier Source: org_study_id